Purification of antibody fragments for the reduction of charge variants using cation exchange chromatography

Hong Jai Lee, Chung Min Lee, Kyunghwa Kim, Jung Min Yoo, Sung muk Kang, Gyong sik Ha, Mi Kyung Park, Min A. Choi, Dong Eok Lee, Baik Lin Seong

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Recently, antibody fragments have been studied as therapeutic agents because they lack Fc effector function while having affinity similar to their original monoclonal antibody and can be produced using E. coli. Antibody fragments can be purified using affinity chromatography in the capture step, although they need a polishing step because of product-related impurities, mainly charge variants. Unlike monoclonal antibodies, few studies exist regarding the separation of charge variants in antibody variants. In this study, an efficient separation of charge variant method was assessed using a cation exchange chromatography resin with salt and a pH gradient. The SP ImpRes resin and pH gradient exhibited the most effective separation potency using combinations of resin and the separation method. The antibody fragment that did not undergo the charge variant separation process exhibited a difference in the tertiary structure of the protein and in vivo pharmacokinetics. However, the antibody fragment was similar to the reference protein when the charge variant separation process was performed. These results are expected to support efficient charge variant separation of antibody fragments and to be applied to the industrial production of therapeutic antibody fragments.

Original languageEnglish
Pages (from-to)20-26
Number of pages7
JournalJournal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences
Volume1080
DOIs
Publication statusPublished - 2018 Mar 30

Fingerprint

Immunoglobulin Fragments
Chromatography
Purification
Cations
Ion exchange
Proton-Motive Force
Monoclonal Antibodies
Cation Exchange Resins
Resins
Affinity chromatography
Pharmacokinetics
Tertiary Protein Structure
Affinity Chromatography
Polishing
Escherichia coli
Salts
Proteins
Impurities
Antibodies
Therapeutics

All Science Journal Classification (ASJC) codes

  • Analytical Chemistry
  • Biochemistry
  • Clinical Biochemistry
  • Cell Biology

Cite this

Lee, Hong Jai ; Lee, Chung Min ; Kim, Kyunghwa ; Yoo, Jung Min ; Kang, Sung muk ; Ha, Gyong sik ; Park, Mi Kyung ; Choi, Min A. ; Lee, Dong Eok ; Seong, Baik Lin. / Purification of antibody fragments for the reduction of charge variants using cation exchange chromatography. In: Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences. 2018 ; Vol. 1080. pp. 20-26.
@article{b6f35c3166e6484f8294baee602f41a6,
title = "Purification of antibody fragments for the reduction of charge variants using cation exchange chromatography",
abstract = "Recently, antibody fragments have been studied as therapeutic agents because they lack Fc effector function while having affinity similar to their original monoclonal antibody and can be produced using E. coli. Antibody fragments can be purified using affinity chromatography in the capture step, although they need a polishing step because of product-related impurities, mainly charge variants. Unlike monoclonal antibodies, few studies exist regarding the separation of charge variants in antibody variants. In this study, an efficient separation of charge variant method was assessed using a cation exchange chromatography resin with salt and a pH gradient. The SP ImpRes resin and pH gradient exhibited the most effective separation potency using combinations of resin and the separation method. The antibody fragment that did not undergo the charge variant separation process exhibited a difference in the tertiary structure of the protein and in vivo pharmacokinetics. However, the antibody fragment was similar to the reference protein when the charge variant separation process was performed. These results are expected to support efficient charge variant separation of antibody fragments and to be applied to the industrial production of therapeutic antibody fragments.",
author = "Lee, {Hong Jai} and Lee, {Chung Min} and Kyunghwa Kim and Yoo, {Jung Min} and Kang, {Sung muk} and Ha, {Gyong sik} and Park, {Mi Kyung} and Choi, {Min A.} and Lee, {Dong Eok} and Seong, {Baik Lin}",
year = "2018",
month = "3",
day = "30",
doi = "10.1016/j.jchromb.2018.01.030",
language = "English",
volume = "1080",
pages = "20--26",
journal = "Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences",
issn = "1570-0232",
publisher = "Elsevier",

}

Purification of antibody fragments for the reduction of charge variants using cation exchange chromatography. / Lee, Hong Jai; Lee, Chung Min; Kim, Kyunghwa; Yoo, Jung Min; Kang, Sung muk; Ha, Gyong sik; Park, Mi Kyung; Choi, Min A.; Lee, Dong Eok; Seong, Baik Lin.

In: Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, Vol. 1080, 30.03.2018, p. 20-26.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Purification of antibody fragments for the reduction of charge variants using cation exchange chromatography

AU - Lee, Hong Jai

AU - Lee, Chung Min

AU - Kim, Kyunghwa

AU - Yoo, Jung Min

AU - Kang, Sung muk

AU - Ha, Gyong sik

AU - Park, Mi Kyung

AU - Choi, Min A.

AU - Lee, Dong Eok

AU - Seong, Baik Lin

PY - 2018/3/30

Y1 - 2018/3/30

N2 - Recently, antibody fragments have been studied as therapeutic agents because they lack Fc effector function while having affinity similar to their original monoclonal antibody and can be produced using E. coli. Antibody fragments can be purified using affinity chromatography in the capture step, although they need a polishing step because of product-related impurities, mainly charge variants. Unlike monoclonal antibodies, few studies exist regarding the separation of charge variants in antibody variants. In this study, an efficient separation of charge variant method was assessed using a cation exchange chromatography resin with salt and a pH gradient. The SP ImpRes resin and pH gradient exhibited the most effective separation potency using combinations of resin and the separation method. The antibody fragment that did not undergo the charge variant separation process exhibited a difference in the tertiary structure of the protein and in vivo pharmacokinetics. However, the antibody fragment was similar to the reference protein when the charge variant separation process was performed. These results are expected to support efficient charge variant separation of antibody fragments and to be applied to the industrial production of therapeutic antibody fragments.

AB - Recently, antibody fragments have been studied as therapeutic agents because they lack Fc effector function while having affinity similar to their original monoclonal antibody and can be produced using E. coli. Antibody fragments can be purified using affinity chromatography in the capture step, although they need a polishing step because of product-related impurities, mainly charge variants. Unlike monoclonal antibodies, few studies exist regarding the separation of charge variants in antibody variants. In this study, an efficient separation of charge variant method was assessed using a cation exchange chromatography resin with salt and a pH gradient. The SP ImpRes resin and pH gradient exhibited the most effective separation potency using combinations of resin and the separation method. The antibody fragment that did not undergo the charge variant separation process exhibited a difference in the tertiary structure of the protein and in vivo pharmacokinetics. However, the antibody fragment was similar to the reference protein when the charge variant separation process was performed. These results are expected to support efficient charge variant separation of antibody fragments and to be applied to the industrial production of therapeutic antibody fragments.

UR - http://www.scopus.com/inward/record.url?scp=85042221716&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85042221716&partnerID=8YFLogxK

U2 - 10.1016/j.jchromb.2018.01.030

DO - 10.1016/j.jchromb.2018.01.030

M3 - Article

C2 - 29459088

AN - SCOPUS:85042221716

VL - 1080

SP - 20

EP - 26

JO - Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

JF - Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

SN - 1570-0232

ER -